Alexa Fluor® 568 Anti-Chk1 antibody [EP691Y],Abcam,AB312723

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Host

Rabbit

Reactivity

Human

Application

Flow Cyt (Intra), Target Binding Affinity, Antibody Labelling, ICC/IF, IHC-P

Conjugate

Alexa Fluor® 568

Platform ID

BAB983018713

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAlexa Fluor® 568 Anti-Chk1 antibody [EP691Y]
Cat. No.AB312723
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationAlexa Fluor® 568
ApplicationFlow Cyt (Intra), Target Binding Affinity, Antibody Labelling, ICC/IF, IHC-P
ClonalityMonoclonal
Clone NumberEP691Y
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856, PubMed : 32357935). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Binds to and phosphorylates CDC25A, CDC25B and CDC25C (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14559997, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C (PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A (PubMed : 19734889, PubMed : 20090422, PubMed : 9278511). Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression (PubMed : 9278511). Also phosphorylates NEK6 (PubMed : 18728393). Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination (PubMed : 15665856). Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation (PubMed : 10673501, PubMed : 15659650, PubMed : 16511572). Also promotes repair of DNA cross-links through phosphorylation of FANCE (PubMed : 17296736). Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A (PubMed : 12660173, PubMed : 12955071). This may enhance chromatin assembly both in the presence or absence of DNA damage (PubMed : 12660173, PubMed : 12955071). May also play a role in replication fork maintenance through regulation of PCNA (PubMed : 18451105). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity). Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest (PubMed : 17380128). Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (PubMed : 31316063). Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (PubMed : 33108758).. Isoform 2. Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition. See full target information CHEK1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.